Citizens National Bank Trust Department’s GSK GSK Stock Holding History

Citizens National Bank Trust Department’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$164K	Hold	3,122	–	–	0.02%	197
2026 Q1	$172K	Buy	3,122 +400	+15%	+$21.7K	0.03%	192
2025 Q4	$134K	Hold	2,722	–	–	0.02%	197
2025 Q3	$117K	Buy	2,722 +1,641	+152%	+$64.1K	0.02%	200
2025 Q2	$41.5K	Hold	1,081	–	–	0.01%	253
2025 Q1	$41.9K	Hold	1,081	–	–	0.01%	254
2024 Q4	$36.6K	Hold	1,081	–	–	0.01%	241
2024 Q3	$44.2K	Hold	1,081	–	–	0.01%	226
2024 Q2	$41.6K	Hold	1,081	–	–	0.01%	231
2024 Q1	$46.4K	Hold	1,081	–	–	0.01%	221
2023 Q4	$40.1K	Hold	1,081	–	–	0.01%	218
2023 Q3	$39.2K	Hold	1,081	–	–	0.01%	217
2023 Q2	$38.5K	Hold	1,081	–	–	0.01%	219
2023 Q1	$38.5K	Hold	1,081	–	–	0.01%	217
2022 Q4	$38K	Hold	1,081	–	–	0.01%	214
2022 Q3	$32K	Sell	1,081 -1	-0.1%	-$38	0.01%	218
2022 Q2	$59K	Buy	1,082 +680	+169%	+$37.5K	0.02%	195
2022 Q1	$23K	Hold	402	–	–	0.01%	232
2021 Q4	$22K	Buy	+402	New	+$20.9K	0.01%	234

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Citizens National Bank Trust Department's GSK Position: Q2 2026 in Review

Citizens National Bank Trust Department held its GSK (GSK) position steady in Q2 2026 at 3,122 shares worth $164K. The position accounts for 0.02% of the portfolio, ranked #197.

Citizens National Bank Trust Department first reported a position in GSK in Q4 2021 and has held it in 19 quarters since. The position peaked at $172K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Citizens National Bank Trust Department held 3,122 shares of GSK worth $164K as of Q2 2026.
Citizens National Bank Trust Department left its GSK share count unchanged in Q2 2026.
GSK made up 0.02% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #197 holding.
Citizens National Bank Trust Department first reported a position in GSK in Q4 2021 and has held it in 19 quarters since.
Citizens National Bank Trust Department's GSK position peaked at $172K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.